cyclosporine has been researched along with Atrophy, Muscle in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 6 (60.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, H; Li, Z; Zhang, J | 1 |
| Afrooz, PN; Bourbeau, D; Lee, WPA; Pulikkottil, BJ; Solari, MG; Unadkat, JV; Washington, KM; Weber, DJ | 1 |
| Bauman, WA; Cardozo, C; Pan, J; Qin, W; Wu, Y | 1 |
| Aoki, MS; Miyabara, EH; Moriscot, AS; Salvini, TF; Soares, AG | 1 |
| Helwig, BG; McAllister, RM; Mitchell, KE; Musch, TI; Weiss, ML; Zbreski, MG | 1 |
| Blesa, R; Dalmau, J; Díaz-Manera, J; Gallardo, E; Illa, I; Juárez, C; Martínez-Domeño, A; Martínez-Ramírez, S; Rojas-García, R | 1 |
| Ogata, T; Ohira, T; Ohira, Y; Oishi, Y; Roy, RR; Taniguchi, K; Terada, M; Yamamoto, KI | 1 |
| Aymerich, H; Ferreira, TA; Molins, N; Pensado, A; Rama-Maceiras, P; Vázquez-Fidalgo, A | 1 |
| Bauerlein, R; Bodine, SC; Glass, DJ; Gonzalez, M; Kline, WO; Lawrence, JC; Scrimgeour, A; Stitt, TN; Stover, GL; Yancopoulos, GD; Zlotchenko, E | 1 |
| Mills, ST; Mitchell, PO; Pavlath, GK | 1 |
10 other study(ies) available for cyclosporine and Atrophy, Muscle
| Article | Year |
|---|---|
A case report of cyclosporine-induced myopathy with subacute muscular atrophy as initial presentation.
Topics: Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Male; Middle Aged; Muscular Atrophy; Muscular Diseases | 2019 |
Functional outcomes following multiple acute rejections in experimental vascularized composite allotransplantation.
Topics: Acute Disease; Animals; Anti-Inflammatory Agents; Cyclosporine; Dexamethasone; Graft Rejection; Hindlimb; Immunosuppressive Agents; Locomotion; Male; Muscular Atrophy; Nerve Regeneration; Neural Conduction; Postoperative Complications; Pulse Therapy, Drug; Rats; Rats, Inbred BN; Rats, Inbred Lew; Recovery of Function; Sciatic Nerve; Transplantation, Homologous | 2013 |
Anabolic steroids activate calcineurin-NFAT signaling and thereby increase myotube size and reduce denervation atrophy.
Topics: Anabolic Agents; Animals; Calcineurin; Cell Nucleus; Cyclosporine; Immunosuppressive Agents; Male; Muscle Denervation; Muscle Fibers, Skeletal; Muscular Atrophy; Nandrolone; Nerve Tissue Proteins; NFATC Transcription Factors; Rats; Rats, Wistar; Signal Transduction | 2015 |
Cyclosporin-A does not affect skeletal muscle mass during disuse and recovery.
Topics: Animals; Calcineurin Inhibitors; Cyclosporine; Enzyme Inhibitors; Hindlimb Suspension; Male; Muscle Fibers, Skeletal; Muscle, Skeletal; Muscular Atrophy; Phenotype; Polymerase Chain Reaction; Rats; Rats, Wistar | 2006 |
Effects of cyclosporine-A on rat soleus muscle fiber size and phenotype.
Topics: Animals; Cyclosporine; Electrophoresis, Polyacrylamide Gel; Immunosuppressive Agents; Male; Muscle Development; Muscle Fibers, Skeletal; Muscle, Skeletal; Muscular Atrophy; Myosin Heavy Chains; Rats; Rats, Sprague-Dawley; United States | 2006 |
Antibodies to AChR, MuSK and VGKC in a patient with myasthenia gravis and Morvan's syndrome.
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Autoantibodies; Cyclosporine; Diagnosis, Differential; Female; Humans; Immunoglobulins, Intravenous; Immunohistochemistry; Immunologic Factors; Middle Aged; Muscle Weakness; Muscular Atrophy; Myasthenia Gravis; Myokymia; Nervous System Diseases; Personality Disorders; Potassium Channels, Voltage-Gated; Prednisone; Receptor Protein-Tyrosine Kinases; Receptors, Cholinergic; Respiratory Insufficiency; Rituximab | 2007 |
Cellular adaptations in soleus muscle during recovery after hindlimb unloading.
Topics: Adaptation, Biological; Animals; Apoptosis; Calcineurin; Calcineurin Inhibitors; Cell Nucleus; Chaperonin 60; Cyclosporine; Electron Transport Complex IV; Enzyme Inhibitors; Hindlimb Suspension; HSP72 Heat-Shock Proteins; Male; Mitochondria, Muscle; Muscle Fibers, Slow-Twitch; Muscle, Skeletal; Muscular Atrophy; Myosin Heavy Chains; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Rats; Rats, Wistar; RNA-Binding Proteins; Transcription Factors | 2008 |
[Prolonged neuromuscular block after a single dose of vecuronium in a patient with undiagnosed polyneuropathy and steroid myopathy].
Topics: Anesthesia Recovery Period; Cyclosporine; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Muscular Atrophy; Nervous System Diseases; Neuromuscular Diseases; Neuromuscular Nondepolarizing Agents; Postoperative Complications; Prednisone; Renal Artery Obstruction; Succinylcholine; Vecuronium Bromide | 1999 |
Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo.
Topics: Animals; Calcineurin; Cardiomegaly; Cyclosporine; Enzyme Inhibitors; Female; Muscle, Skeletal; Muscular Atrophy; Protein Kinases; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Ribosomal Protein S6 Kinases; Signal Transduction; TOR Serine-Threonine Kinases | 2001 |
Calcineurin differentially regulates maintenance and growth of phenotypically distinct muscles.
Topics: Animals; Calcineurin; Calcineurin Inhibitors; Cyclophilins; Cyclosporine; Female; Hindlimb Suspension; Humans; Hypertrophy; Mice; Mice, Inbred BALB C; Models, Biological; Muscle, Skeletal; Muscular Atrophy; Peptidylprolyl Isomerase; Phenotype; Random Allocation; Signal Transduction | 2002 |